Ovid Therapeutics (OVID) Change in Account Payables (2016 - 2026)
Ovid Therapeutics' (OVID) quarterly Change in Account Payables came in at $3.6 million in Q1 2026, up 391.79% YoY from $736903.7 in Q1 2025, and up 1373.17% on a QoQ basis from $246000.0 in Q4 2025.
Ovid Therapeutics (OVID) Change in Account Payables (2016 - 2026) Analysis & Trends
Ovid Therapeutics (OVID) has 11 years of Change in Account Payables data on file, last reported at $3.6 million in Q1 2026.
- Quarterly Change in Account Payables rose 391.79% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (up 320.52% YoY) and the FY2025 annual result came in at -$1.2 million, down 141.02% from the prior year.
- Change in Account Payables climbed to $3.6 million in Q1 2026, from $246000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $3.6 million in Q1 2026 to a low of -$4.9 million in Q1 2022.
- A 5-year average of -$90949.2 and a median of $246000.0 in 2025 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2025 — Change in Account Payables sank 1060.75% — and 2026, when it surged 391.79%.
- Tracing OVID's Change in Account Payables over 5 years: stood at $919844.0 in 2022, then soared by 170.26% to $2.5 million in 2023, then slumped by 80.65% to $481000.0 in 2024, then sank by 48.86% to $246000.0 in 2025, then surged by 1373.17% to $3.6 million in 2026.
- The last three Change in Account Payables figures came in at $3.6 million (Q1 2026), $246000.0 (Q4 2025), and -$2.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ovid Therapeutics | 385.37 Mn | 229.84 Mn | - | 3.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.62 Mn |
| Mar 31, 2026 | 3.62 Mn |
| Dec 31, 2025 | 246,000.00 |
| Dec 31, 2025 | 246,000.00 |
| Sep 30, 2025 | -2.24 Mn |
| Sep 30, 2025 | -2.24 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | -1.24 Mn |
| Mar 31, 2025 | -1.24 Mn |
| Dec 31, 2024 | 481,000.00 |
| Dec 31, 2024 | 481,000.00 |
| Sep 30, 2024 | -2.01 Mn |
| Sep 30, 2024 | -2.01 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | -107,000.00 |
| Mar 31, 2024 | -107,000.00 |
| Dec 31, 2023 | 2.49 Mn |
| Dec 31, 2023 | 2.49 Mn |